Tag Archives: Merck

BMS and Merck Race to Melanoma Treatment Market

Merck’s Keytruda, recently approved in the US to treat patients with advanced melanoma that have stopped responding to other cancer therapies, will soon face strong competition from Bristol-Myers Squibb’s (BMS) Opdivo,  an analyst from research and consulting firm GlobalData has reported.
Posted in Europe, Global, Strategy | Also tagged , , , | Leave a comment

New "Blockbusters" Will Triple Acute Coronary Syndrome Market

The launch of several drugs with “extraordinary blockbuster potential” will more than triple the acute coronary syndrome (ACS) treatment market, from $12.3 billion in 2013 to $43.4 billion by 2023, according to research and consulting firm GlobalData.
Posted in Global, Strategy | Also tagged , , , , , , | Leave a comment

Middle East Meltdown: Diabetes in the Arab Context

Diabetes, it can be said, is one of the unpleasant side-effects of being human. Few other medical conditions are so heavily influenced by lifestyle and patterns of individual behavior, reinforced by a mix of economic, social and cultural factors.  Nowhere do these form a more potent combination than in the Arab countries of the Middle East, […]
Posted in Global, healthcare, Op-Ed | Also tagged , | 1 Comment

Merck in Gender Bias Wrangle

Four class representatives have been added to a class-action gender-discrimination employment suit originally filed last May against Merck & Co. in New Jersey.
Posted in Legal | Also tagged , | Leave a comment

The Pill is Not the Point: Has Pharma Finally Figured out Social Media?

The radical shift currently taking place in pharma marketing is all about partnering with patients rather than talking at them.  In other words, pharma and patients are becoming friends who can help their “partners” educate, design a diet plan, increase disease awareness, and take you to the doctor…well, not quite yet.
Posted in healthcare, multimedia, Patient Communication, social media, Strategy, Technology, Video | Also tagged , , , , , , , | 2 Comments
  • Categories

  • Meta